High-risk Hodgkin's disease prognostic factors
Leuk Lymphoma
.
1995:15 Suppl 1:41-2.
doi: 10.3109/10428199509052704.
Author
D J Straus
1
Affiliation
1
Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York, N.Y. 10021, USA.
PMID:
7767259
DOI:
10.3109/10428199509052704
No abstract available
Publication types
Review
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Hodgkin Disease* / diagnosis
Hodgkin Disease* / mortality
Hodgkin Disease* / therapy
Humans
Survival Rate